Correlation Between Nexalin Technology and Talis Biomedical

Can any of the company-specific risk be diversified away by investing in both Nexalin Technology and Talis Biomedical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nexalin Technology and Talis Biomedical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Nexalin Technology and Talis Biomedical Corp, you can compare the effects of market volatilities on Nexalin Technology and Talis Biomedical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nexalin Technology with a short position of Talis Biomedical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nexalin Technology and Talis Biomedical.

Diversification Opportunities for Nexalin Technology and Talis Biomedical

-0.91

Correlation Coefficient

Nexalin Technology  Talis Biomedical

Pay attention - limited upside

The 3 months correlation between Nexalin and Talis is -0.91. Overlapping area represents the amount of risk that can be diversified away by holding Nexalin Technology and Talis Biomedical Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Talis Biomedical Corp and Nexalin Technology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nexalin Technology are associated (or correlated) with Talis Biomedical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Talis Biomedical Corp has no effect on the direction of Nexalin Technology i.e., Nexalin Technology and Talis Biomedical go up and down completely randomly.

Pair Corralation between Nexalin Technology and Talis Biomedical

Considering the 90-day investment horizon Nexalin Technology is expected to generate 1.68 times more return on investment than Talis Biomedical. However, Nexalin Technology is 1.68 times more volatile than Talis Biomedical Corp. It trades about 0.08 of its potential returns per unit of risk. Talis Biomedical Corp is currently generating about -0.06 per unit of risk. If you would invest  77.00  in Nexalin Technology on August 31, 2024 and sell it today you would earn a total of  341.00  from holding Nexalin Technology or generate 442.86% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Significant
Accuracy	87.45%
Values	Daily Returns

Nexalin Technology  vs.  Talis Biomedical Corp

Nexalin Technology

Risk-Adjusted Performance

19 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Nexalin Technology are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. Despite quite abnormal basic indicators, Nexalin Technology disclosed solid returns over the last few months and may actually be approaching a breakup point.

Talis Biomedical Corp

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Talis Biomedical Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's forward indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Nexalin Technology and Talis Biomedical

The main advantage of trading using opposite Nexalin Technology and Talis Biomedical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nexalin Technology position performs unexpectedly, Talis Biomedical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Talis Biomedical will offset losses from the drop in Talis Biomedical's long position.

The idea behind Nexalin Technology and Talis Biomedical Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.